Edit stance for the indemnity provider to take

<p><strong>Many we have spoken to within the aesthetic industry find this to be an unusual stance for the indemnity provider to take, yet welcome a nod towards those products with a wealth of clinical data to back up their safety, compared to the now saturated levels of CE marked products available with little to substantiate their safety and efficacy.</strong></p> <p><strong>With both the European Parliament and the Keogh Review both looking at the current regulation of medical devices, including dermal fillers, this MDU announcement perhaps is a pre-emptive move towards the likelihood of tighter European and UK regulation of these products in the future. It will be interesting to see if other insurers choose to follow suit or simply pick up extra business as a result of this decision from the MDU.</strong></p>

Selected: Text Block Text Block Full Width Image Banner Image Side By Side Images Left Aligned Image Right Aligned Image Quote Video

Selected: background_7b6cd5 CR Purple Medium Purple Light Purple Dark Pink Light Pink Light Grey Dark Grey No Background Colour